Development of Side-Effect-Free Cancer Cure
Developing a new treatment method that directly approaches pathological stem cells. Traditionally, dysfunctional pathological stem cells hide in bone marrow niches, making it difficult for drugs to reach them effectively. However, by activating these niches, it is possible to expel these pathological stem cells into accessible spaces.
Using this method allows for the reuse of not only new drugs but also drugs that were previously unusable due to side effects. Additionally, cell targeting with Biozipcode ensures that the therapeutic drug is delivered precisely to the target cells. This approach enhances the effectiveness of cancer treatment while minimizing side effects.
Difference Between Molecular Targeting and Cell Targeting
Technology to Deliver Drugs Only to Necessary Parts
Applying cell targeting technology with Biozipcode to conventional anticancer drugs to minimize side effects. Anticancer drugs attack cancer cells but also damage normal cells, leading to side effects. To address this issue, efforts are underway to develop drugs that target only cancer cells.
Specifically, designing drugs that target molecules specifically expressed on the surface of cancer cells or only cancerous cells. This method allows the drug to concentrate on cancer cells without affecting normal cells. Developing an efficient drug delivery system to further enhance the precision of targeting cells.
This research aims to improve patients’ quality of life (QOL) and maximize treatment efficacy. Our ultimate goal is to provide safe and effective cancer treatments with minimal side effects.
Discovery and Research of Diabetes Stem Cells
Abnormal cells were found in hematopoietic stem cell fractions that cause diabetes, which do not disappear even when b/s levels are normalized, creating refractory characteristics.
Discovered that diabetes is a disease caused by abnormalities in hematopoietic stem cells and developed a method to cure diabetes by isolating and eliminating “Diabetes Stem Cells.”
Cell Targeting Technology (Biozipcode)
Aiming to develop cell-targeted drugs as a new drug delivery method for the next generation, beyond the current era of molecular-targeted drugs.
Developing a completely new diabetes and diabetes complication cure using Biozipcode that causes no side effects.
Using cell targeting technology with Biozipcode to develop side-effect-free anticancer drugs, providing treatments that minimize patient burden.
Aiming to develop scaffold materials that promote natural wound healing, adhering to tissues without the need for transplantation or suturing, and enhancing quality of life (QOL).
Are You Interested in Research at the Department of Regenerative Medicine?
Are You Interested in Research at the Department of Regenerative Medicine?
You can send a direct inquiry to the Department of Regenerative Medicine through the contact form.
